|
FY2026
12 months to Mar 31, 2026
|
FY2025
12 months to Mar 31, 2025
|
|
|---|---|---|
| Cash Flows from Operating Activities: | ||
| Net income (loss) | ||
| Adjustments to reconcile net cash used in operating activities: | ||
| Formation and operating costs paid by Sponsor | ||
| Amortization of prepaid expenses | ||
| Interest earned on investments held in Trust Account | ||
| Changes in operating assets and liabilities | ||
| Prepaid expenses | ||
| Accrued expenses | ||
| Due to Sponsor | ||
| Net cash used in operating activities | ||
| Cash Flows from Investing Activity: | ||
| Investment of cash in trust account | ||
| Net cash used in investing activity | ||
| Cash Flows from Financing Activities: | ||
| Proceeds from promissory note payable - related party | ||
| Repayment of promissory note payable - related party | ||
| Proceeds from sale of public units through public offerings, net of underwriters’ discount | ||
| Proceeds from ordinary shares issued in private placement | ||
| Payment of deferred offering costs | ||
| Net cash generated by financing activities | ||
| Net change in cash | ||
| Cash at beginning of year | ||
| Cash at end of the year | ||
| Supplemental Disclosure of Non-cash Activities | ||
| Deferred offering costs paid by Sponsor in exchange for the issuance of ordinary shares | ||
| Initial classification of ordinary shares subject to possible redemption | ||
| Allocation of offering costs to ordinary shares subject to possible redemption | ||
| Representative shares issued and charged to offering costs | ||
| Accretion of ordinary shares subject to redemption value | ||
| Sponsor Subsequent measurement of ordinary shares subject to redemption (additional funding for business combination extension) | ||
| Deferred offering costs included in accrued expenses | ||
| Deferred offering cost paid by Sponsor | ||
| Paid off the advances from Sponsor balance by drawing down on the promissory note |
Loading...
